NASDAQ: CADLCandel Therapeutics Inc Stock Ownership - Who owns Candel Therapeutics?
Insider buying vs selling
Have Candel Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William Garrett Nichols | Chief Medical Officer | 2025-07-28 | 937 | $6.98 | $6.54kSell |
| William Garrett Nichols | Chief Medical Officer | 2025-07-28 | 937 | $1.29 | $1.21kBuy |
| William Garrett Nichols | Chief Medical Officer | 2025-06-30 | 781 | $1.29 | $1.01kBuy |
| William Garrett Nichols | Chief Medical Officer | 2025-06-30 | 781 | $5.04 | $3.94kSell |
| Paul Peter Tak | Chief Executive Officer | 2025-06-25 | 42,826 | $4.67 | $200.00kBuy |
| Charles Schoch | Chief Financial Officer | 2025-06-25 | 5,353 | $4.67 | $25.00kBuy |
| Paul B. Manning | Director | 2025-06-25 | 1,070,663 | $4.67 | $5.00MBuy |
| Seshu Tyagarajan | Chief Technology Officer | 2025-06-25 | 5,353 | $4.67 | $25.00kBuy |
| Francesca Barone | Chief Scientific Officer | 2025-06-25 | 4,282 | $4.67 | $20.00kBuy |
| Gary J. Nabel | Director | 2025-06-25 | 5,353 | $4.67 | $25.00kBuy |
CADL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CADL insiders and whales buy or sell their stock.
CADL Shareholders
What type of owners hold Candel Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 15.00% | 8,233,385 | $52.28M | Institution |
| Estuardo Aguilarcordova | 13.04% | 7,156,946 | $45.45M | Insider |
| Paul B. Manning | 9.47% | 5,197,821 | $33.01M | Insider |
| Laura K. Aguilar | 5.55% | 3,046,940 | $19.35M | Insider |
| Acorn Capital Advisors LLC | 4.70% | 2,580,517 | $16.39M | Institution |
| Blackrock Inc | 4.33% | 2,379,330 | $15.11M | Institution |
| Vanguard Group Inc | 3.66% | 2,007,112 | $12.75M | Institution |
| Portolan Capital Management LLC | 2.52% | 1,384,142 | $8.79M | Institution |
| Geode Capital Management LLC | 1.69% | 928,197 | $5.89M | Institution |
| Christopher Martell | 1.27% | 698,863 | $4.44M | Insider |
CADL vs Biotech Stocks
Candel Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.